Abiopharma

Tilray Medical renforce sa présence en Allemagne en introduisant de nouvelles variétés de cannabis thérapeutique Good Supply

New Form 144 - NEXGEL, INC. Filed: 2025-08-28 AccNo: 0001949846-25-000432 Size: 7 KB

Northwest Biotherapeutics Announces Agreement to Acquire Advent BioServices Ltd.

Securities Fraud Investigation Into LifeMD, Inc. (LFMD) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

Deadline Alert: Nutex Health Inc. (NUTX) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

Indivior Notification

New Form 144 - INDIVIOR PLC Filed: 2025-08-28 AccNo: 0001974494-25-000091 Size: 4 KB

QIAGEN N.V. Announces Successful Placement of New Net Share Settled Convertible Bonds

New Form 144 - Progyny, Inc. Filed: 2025-08-28 AccNo: 0001959173-25-005596 Size: 4 KB

New Form 6-K - ASTRAZENECA PLC Filed: 2025-08-28 AccNo: 0001654954-25-010131 Size: 17 KB

The latest from NRC Health | Read the August nSight, find the keys to human-centered design, and so much more!

Zealand Pharma to participate in upcoming investor conferences in September 2025

Hemostemix Announces Financing Plans for VesCell™ Treatment

New Form 6-K - Biophytis SA Filed: 2025-08-28 AccNo: 0001104659-25-084446 Size: 27 KB

New Form 8-K - Fulcrum Therapeutics, Inc. Filed: 2025-08-28 AccNo: 0001193125-25-190746 Size: 15 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits